What’s at Stake in the Off-Label Debate: Freedom of speech may be the legal...
There are enough legal issues in this case to keep a boatload of constitutional and pharma lawyers busy for years. But let's look at this from a different perspective -- i.e., what pharma has to gain from this and what patients have to lose.
Google’s New Drug Search Result Format: A “Knowledge Graph” that doesn’t include pharma!
Google launched a new drug search result format that includes data from the U.S. FDA, the National Library of Medicine, and the Department of Veterans Affairs, among othersbut apparently not directly from pharmaceutical companies.
The Year 2012 in Images: A Select Review of Pharma Industry News & Trends
These are Pharmaguy's favorite images and stories published on Pharma Marketing Blog during 2012. It's a good summary of some of the major trends in the industry.
Dear Santa from Pharma: “Please, Sir, May I Have More?”
In the "Pharma's 2011 Christmas Wish List for Santa" survey, I had a list of items for Santa to deliver to the pharmaceutical industry....
FDA’s “Social Media Guidance Cliff”: An Open Letter to Megan Clark Velez
FDA will communicate its progress towards accomplishing the requirements of the FDA Safety and Innovation Act (FDASIA) by updating an online chart/database on a...
Pharma’s Adherence Revenue Pipe Dream
You've seen the headlines:
"Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to Medication Non-Adherence"
"Poor adherence costs...
U.S. Brand Drug Prices Take Flight While Generic Prices Plummet
Express Scripts just published its "Inaugural Drug Trend Quarterly," which provides the "first comprehensive overview of U.S. prescription drug spending for 2012 (see press...
What Pharma Can Learn from Dexter
Pharma marketers are often urged to learn from other industries. Well, I have something that pharma marketers/communicators can learn from Dexter, "America's favorite serial...
How Many Sales Reps is One Key Opinion Leader Worth?
Remember Marcia Angell, former editor in chief of the New England Journal of Medicine? She wrote the book "The Truth About the Drug Companies:...
Pharma COPD Campaigns Abound, Yet Public’s Awareness of COPD Declines
According to the U.S. Department of Health and Human Services, awareness of chronic obstructive pulmonary disease (COPD) has been rising gradually in recent years,...
















